Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-004626
Filing Date
2024-08-09
Accepted
2024-08-09 14:56:53
Documents
48
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thct_10q.htm   iXBRL 10-Q 595295
2 CERTIFICATION thct_ex311.htm EX-31.1 10736
3 CERTIFICATION thct_ex321.htm EX-32.1 4079
  Complete submission text file 0001477932-24-004626.txt   2990853

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA thct-20231031.xsd EX-101.SCH 30066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20231031_lab.xml EX-101.LAB 176704
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20231031_cal.xml EX-101.CAL 33875
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20231031_pre.xml EX-101.PRE 150388
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20231031_def.xml EX-101.DEF 90313
51 EXTRACTED XBRL INSTANCE DOCUMENT thct_10q_htm.xml XML 418892
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 241192109
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)